Ko Y, Abel J, Harth V et al (2001) Association of CYP1B1 codon 432 mutant allele in head and
neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res
61:4398–4404
Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review.
Mutat Res 463:247–283
Landi MT, Sinha R, Lang NP et al (1999) Human cytochrome P4501A2. IARC Sci Publ
148:179–195
Lee EJ, Wong JY, Yeoh PN et al (1995) Glutathione S-transferase theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics 5:332–334
Li G, Liu Z, Sturgis EM et al (2005) CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1
Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the
head and neck. Cancer Epidemiol Biomark Prev 14:1034–1036
Li D, Jiao L, Li Y et al (2006) Polymorphisms of cytochrome P4501A2 and N-acetyltransferase
genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27:103–111
McIlwain C, Townsend D, Tew K (2006) Glutathione S-transferase polymorphisms: cancer
incidence and therapy. Oncogene 25:1639–1648
Mhatre S, Wang Z, Nagrani R et al (2017) Common genetic variation and risk of gallbladder cancer
in India: a case-control genome-wide association study. Lancet Oncol 18:535–544
Morrow CS, Cowan KH, Goldsmith ME (1989) Structure of the human genomic glutathione Stransferase-pi gene. Gene 75:3–11
Mukherji B (2013) Immunology of melanoma. Clin Dermatol 31:156–165
Murata M, Takayama K, Choi B et al (1996) A nested case-control study on alcohol drinking,
tobacco smoking, and cancer. Cancer Detect Prev 20:557–565
Nakajima T, Aoyama T (2000) Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Ind Health 38:143–152
Nakajima M, Yokoi T, Mizutani M et al (1999) Genetic polymorphism in the 5
0 -flanking region of
human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo)
125:803–808
Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet
360:1155–1162
Nelson DR, Koymans L, Kamataki T et al (1996) P450 superfamily: update on new sequences, gene
mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42
Neufeld KJ, Peters DH, Rani M et al (2005) Regular use of alcohol, and tobacco in India and its
association with age, gender and poverty. Drug Alcohol Depend 77:283–291
Newsholme A (1903) The possible association of the consumption of alcohol with excessive
mortality from cancer. Br Med J 2:1529–1531
Nora H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309–334
Oscarson M (2001) Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene:
implications for interindividual differences in nicotine metabolism. Drug Metab Dispos
29:91–95
Ottman R (1996) Gene-environment interaction: definitions and study designs. Prev Med
25:764–770
Pandey SN, Choudhuri G, Mittal B (2008) Association of CYP1A1 Msp1 polymorphism with
tobacco-related risk of gallbladder cancer in a north Indian population. Eur J Cancer Prev
17:77–81
Patten CJ, Smith TJ, Friesen MJ et al (1997) Evidence for cytochrome P450 2A6 and 3A4 as major
catalysts for N
0 -nitrosonornicotine alpha-hydroxylation by human liver microsomes. Carcinogenesis 18:1623–1630
Perera FP, Whyatt R (1994) Biomarkers and molecular epidemiology in mutation/cancer research.
Mutat Res 313:117–129
Persson I, Johansson I, Bergling H et al (1993) Genetic polymorphism of cytochrome P4502E1 in a
Swedish population relationship to incidence of lung cancer. FEBS Lett 319:207–211
10 Interactions of Environmental Risk Factors and Genetic Variations: Association. . .
231
neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res
61:4398–4404
Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review.
Mutat Res 463:247–283
Landi MT, Sinha R, Lang NP et al (1999) Human cytochrome P4501A2. IARC Sci Publ
148:179–195
Lee EJ, Wong JY, Yeoh PN et al (1995) Glutathione S-transferase theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics 5:332–334
Li G, Liu Z, Sturgis EM et al (2005) CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1
Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the
head and neck. Cancer Epidemiol Biomark Prev 14:1034–1036
Li D, Jiao L, Li Y et al (2006) Polymorphisms of cytochrome P4501A2 and N-acetyltransferase
genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27:103–111
McIlwain C, Townsend D, Tew K (2006) Glutathione S-transferase polymorphisms: cancer
incidence and therapy. Oncogene 25:1639–1648
Mhatre S, Wang Z, Nagrani R et al (2017) Common genetic variation and risk of gallbladder cancer
in India: a case-control genome-wide association study. Lancet Oncol 18:535–544
Morrow CS, Cowan KH, Goldsmith ME (1989) Structure of the human genomic glutathione Stransferase-pi gene. Gene 75:3–11
Mukherji B (2013) Immunology of melanoma. Clin Dermatol 31:156–165
Murata M, Takayama K, Choi B et al (1996) A nested case-control study on alcohol drinking,
tobacco smoking, and cancer. Cancer Detect Prev 20:557–565
Nakajima T, Aoyama T (2000) Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Ind Health 38:143–152
Nakajima M, Yokoi T, Mizutani M et al (1999) Genetic polymorphism in the 5
0 -flanking region of
human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo)
125:803–808
Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet
360:1155–1162
Nelson DR, Koymans L, Kamataki T et al (1996) P450 superfamily: update on new sequences, gene
mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42
Neufeld KJ, Peters DH, Rani M et al (2005) Regular use of alcohol, and tobacco in India and its
association with age, gender and poverty. Drug Alcohol Depend 77:283–291
Newsholme A (1903) The possible association of the consumption of alcohol with excessive
mortality from cancer. Br Med J 2:1529–1531
Nora H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309–334
Oscarson M (2001) Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene:
implications for interindividual differences in nicotine metabolism. Drug Metab Dispos
29:91–95
Ottman R (1996) Gene-environment interaction: definitions and study designs. Prev Med
25:764–770
Pandey SN, Choudhuri G, Mittal B (2008) Association of CYP1A1 Msp1 polymorphism with
tobacco-related risk of gallbladder cancer in a north Indian population. Eur J Cancer Prev
17:77–81
Patten CJ, Smith TJ, Friesen MJ et al (1997) Evidence for cytochrome P450 2A6 and 3A4 as major
catalysts for N
0 -nitrosonornicotine alpha-hydroxylation by human liver microsomes. Carcinogenesis 18:1623–1630
Perera FP, Whyatt R (1994) Biomarkers and molecular epidemiology in mutation/cancer research.
Mutat Res 313:117–129
Persson I, Johansson I, Bergling H et al (1993) Genetic polymorphism of cytochrome P4502E1 in a
Swedish population relationship to incidence of lung cancer. FEBS Lett 319:207–211
10 Interactions of Environmental Risk Factors and Genetic Variations: Association. . .
231